tradingkey.logo

PMV Pharmaceuticals Inc <PMVP.OQ> expected to post a loss of 37 cents a share - Earnings Preview

ReutersMay 5, 2025 1:44 PM
  • PMV Pharmaceuticals Inc PMVP.OQ PMVP.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for PMV Pharmaceuticals Inc is for a loss of 37 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 1.1% in the last three months. ​

  • Wall Street's median 12-month price target for PMV Pharmaceuticals Inc is $6.00​, above​ its last closing price of $1.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.39

-0.38

-0.45

Missed

-18.2

Sep. 30 2024

-0.36

-0.35

-0.37

Missed

-5.4

Jun. 30 2024

-0.35

-0.35

-0.02

Beat

94.3​

Mar. 31 2024

-0.35

-0.36

-0.30

Beat

16.8

​​Dec. 31 2023

-0.38

-0.39

-0.31

Beat

19.7

Sep. 30 2023

-0.45

-0.45

-0.34

Beat

23.8​

Jun. 30 2023

-0.46

-0.47

-0.38

Beat

20

Mar. 31 2023

-0.44

-0.46

-0.42

Beat

8.4

This summary was machine generated May 5 at 13:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI